These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18499722)

  • 1. Unresolved issues and controversies in purinergic signalling.
    Burnstock G
    J Physiol; 2008 Jul; 586(14):3307-12. PubMed ID: 18499722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic signalling: past, present and future.
    Burnstock G
    Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic receptors and pain.
    Burnstock G
    Curr Pharm Des; 2009; 15(15):1717-35. PubMed ID: 19442186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic signalling: pathophysiology and therapeutic potential.
    Burnstock G
    Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview. Purinergic mechanisms.
    Burnstock G
    Ann N Y Acad Sci; 1990; 603():1-17; discussion 18. PubMed ID: 1981306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance.
    Verkhratsky A; Burnstock G
    Bioessays; 2014 Jul; 36(7):697-705. PubMed ID: 24782352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic signalling in the kidney in health and disease.
    Burnstock G; Evans LC; Bailey MA
    Purinergic Signal; 2014 Mar; 10(1):71-101. PubMed ID: 24265071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic signalling.
    Burnstock G
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S172-81. PubMed ID: 16402102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introductory overview of purinergic signalling.
    Burnstock G
    Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The birth and postnatal development of purinergic signalling.
    Burnstock G; Fredholm BB; North RA; Verkhratsky A
    Acta Physiol (Oxf); 2010 Jun; 199(2):93-147. PubMed ID: 20345419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical review: ATP as a neurotransmitter.
    Burnstock G
    Trends Pharmacol Sci; 2006 Mar; 27(3):166-76. PubMed ID: 16487603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic signalling--an overview.
    Burnstock G
    Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic signalling in neuron-glia interactions.
    Fields RD; Burnstock G
    Nat Rev Neurosci; 2006 Jun; 7(6):423-36. PubMed ID: 16715052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic signaling in the retina: From development to disease.
    Ventura ALM; Dos Santos-Rodrigues A; Mitchell CH; Faillace MP
    Brain Res Bull; 2019 Sep; 151():92-108. PubMed ID: 30458250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic signalling: an experimental perspective.
    Housley GD; Thorne PR
    J Auton Nerv Syst; 2000 Jul; 81(1-3):139-45. PubMed ID: 10869712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction.
    Ruggieri MR
    Nat Clin Pract Urol; 2006 Apr; 3(4):206-15. PubMed ID: 16607369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
    Burnstock G
    Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic regulation of sound transduction and auditory neurotransmission.
    Housley GD; Jagger DJ; Greenwood D; Raybould NP; Salih SG; Järlebark LE; Vlajkovic SM; Kanjhan R; Nikolic P; Muñoz DJ; Thorne PR
    Audiol Neurootol; 2002; 7(1):55-61. PubMed ID: 11914528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic targets in the rapidly expanding field of purinergic signalling.
    Burnstock G
    Clin Med (Lond); 2002; 2(1):45-53. PubMed ID: 11871639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibers.
    Lawrence GW; Aoki KR; Dolly JO
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1080-6. PubMed ID: 20576797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.